Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 730301, 15 pages
http://dx.doi.org/10.1155/2014/730301
Review Article

Human AP Endonuclease 1: A Potential Marker for the Prediction of Environmental Carcinogenesis Risk

1Environmental Health Research Department, National Institute of Environmental Research, 42 Hwangyeong-ro, Seo-gu, Incheon 404-708, Republic of Korea
2School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea
3Department of Life Science, Institute of Environmental Medicine, Dongguk University, 30 Pildong-ro 1-gil, Jung-gu, Seoul 100-715, Republic of Korea
4Department of Safety Engineering, Dongguk University, Gyeongju, Gyeongbuk 780-714, Republic of Korea
5Department of Food and Nutrition, Sookmyung Women’s University, Cheong-ro 47-gil 100, Youngsan-gu, Seoul 140-742, Republic of Korea

Received 25 April 2014; Accepted 30 June 2014; Published 26 August 2014

Academic Editor: Jing Yi

Copyright © 2014 Jae Sung Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Tell, D. Fantini, and F. Quadrifoglio, “Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment,” Cellular and Molecular Life Sciences, vol. 67, no. 21, pp. 3589–3608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Xanthoudakis, G. G. Miao, and T. Curran, “The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 23–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Luo, S. Delaplane, A. Jiang et al., “Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1,” Antioxidants and Redox Signaling, vol. 10, no. 11, pp. 1853–1867, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. McNeill and D. M. Wilson III, “A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents,” Molecular Cancer Research, vol. 5, no. 1, pp. 61–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. R. Evans, M. Limp-Foster, and M. R. Kelley, “Going APE over ref-1,” Mutation Research-DNA Repair, vol. 461, no. 2, pp. 83–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Georgiadis, M. Luo, R. K. Gaur, S. Delaplane, X. Li, and M. R. Kelley, “Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 643, no. 1-2, pp. 54–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Fantini, C. Vascotto, D. Marasco et al., “Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions,” Nucleic Acids Research, vol. 38, no. 22, pp. 8239–8256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Park and Y. R. Seo, “The protective role of Nrf2 in cadmium-induced DNA damage,” Molecular and Cellular Toxicology, vol. 7, no. 1, pp. 61–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. L. Kim and Y. R. Seo, “Synergistic genotoxic effect between gene and environmental pollutant: oxidative DNA damage induced by thioredoxin reductase 1 silencing under nickel treatment,” Molecular and Cellular Toxicology, vol. 7, no. 3, pp. 251–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Y. Park, Y. J. Lee, P. Koedrith, and Y. R. Seo, “Protective role of thioredoxin reductase 1 in cadmium-induced DNA damage,” Molecular and Cellular Toxicology, vol. 8, no. 3, pp. 289–295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. L. Kim and Y. R. Seo, “Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 defciency and carcinogenic nickel-induced DNA damage,” Oncology Reports, vol. 28, no. 6, pp. 1959–1967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. P. T. Beernink, B. W. Segelke, M. Z. Hadi, J. P. Erzberger, D. M. Wilson III, and B. Rupp, “Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism,” Journal of Molecular Biology, vol. 307, no. 4, pp. 1023–1034, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. X. Li and D. M. Wilson, “Human apurinic/apyrimidinic endonuclease 1,” Antioxidants & Redox Signaling, vol. 20, no. 4, pp. 678–707, 2014. View at Google Scholar
  14. G. Tell, F. Quadrifoglio, C. Tiribelli, and M. R. Kelley, “The many functions of APE1/Ref-1: not only a DNA repair enzyme,” Antioxidants and Redox Signaling, vol. 11, no. 3, pp. 601–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. M. Flaherty, M. M. Monick, and G. W. Hunninghake, “AP endonucleases and the many functions of Ref-1,” The American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 6, pp. 664–667, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Izumi, D. B. Brown, C. V. Naidu et al., “Two essential but distinct functions of the mammalian abasic endonuclease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5739–5743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Marenstein, D. M. Wilson III, and G. W. Teebor, “Human AP endonuclease (APE1) demonstrates endonucleolytic activity against AP sites in single-stranded DNA,” DNA Repair, vol. 3, no. 5, pp. 527–533, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. M. Wilson III and D. Barsky, “The major human abasic endonuclease: Formation, consequences and repair of abasic lesions in DNA,” Mutation Research/DNA Repair, vol. 485, no. 4, pp. 283–307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Loeb and B. D. Preston, “Mutagenesis by apurinic/apyrimidinic sites,” Annual Review of Genetics, vol. 20, pp. 201–230, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Seeberg, L. Eide, and M. Bjoras, “The base excision repair pathway,” Trends in Biochemical Sciences, vol. 20, no. 10, pp. 391–397, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. T. A. Winters, W. D. Henner, P. S. Russell, A. McCullough, and T. J. Jorgensen, “Removal of 3′-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1,” Nucleic Acids Research, vol. 22, no. 10, pp. 1866–1873, 1994. View at Google Scholar · View at Scopus
  22. D. Suh, D. M. Wilson III, and L. F. Povirk, “3-Phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends,” Nucleic Acids Research, vol. 25, no. 12, pp. 2495–2500, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Barzilay, C. D. Mol, C. N. Robson et al., “Identification of critical active-site residues in the multifunctional human DNA repair enzyme HAP1,” Nature Structural Biology, vol. 2, no. 7, pp. 561–568, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Wilson III, M. Takeshita, A. P. Grollman, and B. Demple, “Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA,” Journal of Biological Chemistry, vol. 270, no. 27, pp. 16002–16007, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. D. S. Chen, T. Herman, and B. Demple, “Two distinct human DNA diesterases that hydrolyze 3′-blocking deoxyribose fragments from oxidized DNA,” Nucleic Acids Research, vol. 19, no. 21, pp. 5907–5914, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Demple and L. Harrison, “Repair of oxidative damage to DNA: enzymology and biology,” Annual Review of Biochemistry, vol. 63, pp. 915–948, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Wiederhold, J. B. Leppard, P. Kedar et al., “AP endonuclease-independent DNA base excision repair in human cells,” Molecular Cell, vol. 15, no. 2, pp. 209–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Izumi, L. R. Wiederhold, G. Roy et al., “Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage,” Toxicology, vol. 193, no. 1-2, pp. 43–65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Flaherty, M. M. Monick, A. B. Carter, M. W. Peterson, and G. W. Hunninghake, “Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages,” Journal of Immunology, vol. 168, no. 11, pp. 5675–5681, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. T. K. Hazra, Y. W. Kow, Z. Hatahet et al., “Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30417–30420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Tell, G. Damante, D. Caldwell, and M. R. Kelley, “The intracellular localization of APE1/Ref-1: more than a passive phenomenon?” Antioxidants and Redox Signaling, vol. 7, no. 3-4, pp. 367–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. I. I. Dianova, V. A. Bohr, and G. L. Dianov, “Interaction of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair,” Biochemistry, vol. 40, no. 42, pp. 12639–12644, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Kim, S. Biade, and Y. Matsumoto, “Involvement of flap endonuclease 1 in base excision DNA repair,” The Journal of Biological Chemistry, vol. 273, no. 15, pp. 8842–8848, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Klungland and T. Lindahl, “Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1),” The EMBO Journal, vol. 16, no. 11, pp. 3341–3348, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. H. J. Jung, E. H. Kim, J.-Y. Mun et al., “Base excision DNA repair defect in Gadd45a-deficient cells,” Oncogene, vol. 26, no. 54, pp. 7517–7525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. L. Kim, S. U. Kim, and Y. R. Seo, “A novel role for Gadd45α in base excision repair: modulation of APE1 activity by the direct interaction of Gadd45α with PCNA,” Biochemical and Biophysical Research Communications, vol. 434, no. 2, pp. 185–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Jung, H. L. Kim, Y. J. Kim, J. Weon, and Y. R. Seo, “A novel chemopreventive mechanism of selenomethionine: enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair,” Oncology Reports, vol. 30, no. 4, pp. 1581–1586, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. K. W. Caldecott, “DNA single-strand break repair and spinocerebellar ataxia,” Cell, vol. 112, no. 1, pp. 7–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Taylor, D. J. Moore, J. Whitehouse, P. Johnson, and K. W. Caldecott, “A cell cycle-specific requirement for the XRCC1 BRCT II domain during mammalian DNA strand break repair,” Molecular and Cellular Biology, vol. 20, no. 2, pp. 735–740, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. A. E. Vidal, S. Boiteux, I. D. Hickson, and J. P. Radicella, “XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions,” The EMBO Journal, vol. 20, no. 22, pp. 6530–6539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Burkart, H. Liu, K. Bellmann et al., “Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70,” Journal of Biological Chemistry, vol. 275, no. 26, pp. 19521–19528, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Mendez, M. Sandigursky, W. A. Franklin, M. K. Kenny, R. Kureekattil, and R. Bases, “Heat-shock proteins associated with base excision repair enzymes in HeLa cells,” Radiation Research, vol. 153, no. 2, pp. 186–195, 2000. View at Google Scholar · View at Scopus
  43. M. K. Kenny, F. Mendez, M. Sandigursky et al., “Heat shock protein 70 binds to human apurinic/apyrimidinic endonuclease and stimulates endonuclease activity at abasic sites,” Journal of Biological Chemistry, vol. 276, no. 12, pp. 9532–9536, 2001. View at Google Scholar
  44. F. Mendez, M. Sandigursky, R. P. Kureekattil, M. K. Kenny, W. A. Franklin, and R. Bases, “Specific stimulation of human apurinic/apyrimidinic endonuclease by heat shock protein 70,” DNA Repair, vol. 2, no. 3, pp. 259–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. M. R. Kelley and S. H. Parsons, “Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1,” Antioxidants and Redox Signaling, vol. 3, no. 4, pp. 671–683, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. M. R. Kelley, M. M. Georgiadis, and M. L. Fishel, “APE1/Ref-1role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1,” Current Molecular Pharmacology, vol. 5, no. 1, pp. 36–53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi, “Ap-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 3633–3638, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. L. J. Walker, C. N. Robson, E. Black, D. Gillespie, and I. D. Hickson, “Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding,” Molecular and Cellular Biology, vol. 13, no. 9, pp. 5370–5376, 1993. View at Google Scholar · View at Scopus
  49. C. D. Mol, T. Izumi, S. Mitra, and J. A. Talner, “DNA-bound structures and mutants reveal abasic DNA binding by APE1 DNA repair and coordination,” Nature, vol. 403, no. 6768, pp. 451–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. H. Luo, J. Zhang, H. Z. He et al., “Characterization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease,” Biochemistry, vol. 51, no. 2, pp. 695–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Xanthoudakis and T. Curran, “Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity,” The EMBO Journal, vol. 11, no. 2, pp. 653–665, 1992. View at Google Scholar · View at Scopus
  52. X. Cao, F. Kambe, S. Ohmori, and H. Seo, “Oxidoreductive modification of two cysteine residues in paired domain by Ref-1 regulates DNA-binding activity of Pax-8,” Biochemical and Biophysical Research Communications, vol. 297, no. 2, pp. 288–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Ema, K. Hirota, J. Mimura et al., “Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300,” The EMBO Journal, vol. 18, no. 7, pp. 1905–1914, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Hirota, M. Murata, Y. Sachi et al., “Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB,” Journal of Biological Chemistry, vol. 274, no. 39, pp. 27891–27897, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Lando, I. Pongratz, L. Poellinger, and M. L. Whitelaw, “A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor,” The Journal of Biological Chemistry, vol. 275, no. 7, pp. 4618–4627, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Tell, A. Zecca, L. Pellizzari et al., “An “environment to nucleus” signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation,” Nucleic Acids Research, vol. 28, no. 5, pp. 1099–1105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Ueno, H. Masutani, R. J. Arai et al., “Thioredoxin-dependent redox regulation of p53-mediated p21 activation,” Journal of Biological Chemistry, vol. 274, no. 50, pp. 35809–35815, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Akamatsu, T. Ohno, K. Hirota, H. Kagoshima, J. Yodoi, and K. Shigesada, “Redox regulation of the DNA binding activity in transcription factor PEBP2 the roles of two conserved cysteine residues: the roles of two conserved cysteine residues,” The Journal of Biological Chemistry, vol. 272, no. 23, pp. 14497–14500, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. R. P. Huang and E. D. Adamson, “Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism,” DNA and Cell Biology, vol. 12, no. 3, pp. 265–273, 1993. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Xanthoudakis, G. Miao, F. Wang, Y. C. Pan, and T. Curran, “Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme,” Journal of Cellular Biochemistry, vol. 11, no. 9, pp. 3323–3335, 1993. View at Google Scholar
  61. C. Abate, L. Patel, F. J. Rauscher III, and T. Curran, “Redox regulation of Fos and Jun DNA-binding activity in vitro,” Science, vol. 249, no. 4973, pp. 1157–1161, 1990. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Jayaraman, K. G. K. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives, “Identification of redox/repair protein Ref-1 as a potent activator of p53,” Genes and Development, vol. 11, no. 5, pp. 558–570, 1997. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Hainaut and J. Milner, “Redox modulation of p53 conformation and sequence-specific DNA binding in vitro,” Cancer Research, vol. 53, no. 18, pp. 4469–4473, 1993. View at Google Scholar · View at Scopus
  64. M.-H. Luo, H.-Z. He, M. R. Kelley, and M. M. Georgiadis, “Redox regulation of DNA repair: implications for human health and cancer therapeutic development,” Antioxidants & Redox Signaling, vol. 12, no. 11, pp. 1247–1269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Sengupta and C. C. Harris, “p53: traffic cop at the crossroads of DNA repair and recombination,” Nature Reviews Molecular Cell Biology, vol. 6, no. 1, pp. 44–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. H. K. Hamadeh, K. J. Trouba, R. P. Amin, C. A. Afshari, and D. Germolec, “Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes,” Toxicological Sciences, vol. 69, no. 2, pp. 306–316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. A. S. Andrew, A. J. Warren, A. Barchowsky et al., “Genomic and proteomic profiling of responses to toxic metals in human lung cells,” Environmental Health Perspectives, vol. 111, no. 6, pp. 825–838, 2003. View at Google Scholar · View at Scopus
  68. Y. Hu, X. M. Jin, and E. T. Snow, “Effect of arsenic on transcription factor AP-1 and NF-κB DNA binding activity and related gene expression,” Toxicology Letters, vol. 133, no. 1, pp. 33–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Sykora and E. T. Snow, “Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite,” Toxicology and Applied Pharmacology, vol. 228, no. 3, pp. 385–394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Fung, P. Liu, and B. Demple, “ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis,” Molecular and Cellular Biology, vol. 27, no. 24, pp. 8834–8847, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Fujihara, M. Soejima, T. Yasuda et al., “Polymorphic trial in oxidative damage of arsenic exposed Vietnamese,” Toxicology and Applied Pharmacology, vol. 256, no. 2, pp. 174–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. C. V. Breton, W. Zhou, M. L. Kile et al., “Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes,” Carcinogenesis, vol. 28, no. 7, pp. 1520–1525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. D. R. McNeill, A. Narayana, H. Wong, and D. M. Wilson III, “Inhibition of Ape1 nuclease activity by lead, iron, and cadmium,” Environmental Health Perspectives, vol. 112, no. 7, pp. 799–804, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Hamann, C. König, C. Richter, G. Jahnke, and A. Hartwig, “Impact of cadmium on hOGG1 and APE1 as a function of the cellular p53 status,” Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 736, no. 1-2, pp. 56–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. S. A. Al Bakheet, I. M. Attafi, Z. H. Maayah, A. R. Abd-Allah, Y. A. Asiri, and H. M. Korashy, “Effect of long-term human exposure to environmental heavy metals on the expression of detoxification and DNA repair genes,” Environmental Pollution, vol. 181, pp. 226–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Bravard, A. Campalans, M. Vacher et al., “Inactivation by oxidation and recruitment into stress granules of hOGG1 but not APE1 in human cells exposed to sub-lethal concentrations of cadmium,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 685, no. 1-2, pp. 61–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Scortegagna and I. Hanbauer, “Increased AP-1 DNA-binding activity and nuclear REF-1 accumulation in lead-exposed primary cultures of astrocytes,” Neurochemical Research, vol. 25, no. 6, pp. 861–866, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. J. García-Lestón, J. Roma-Torres, M. Vilares et al., “Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair,” Environment International, vol. 43, no. 1, pp. 29–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. S. la Maestra, G. E. Kisby, R. T. Micale et al., “Cigarette smoke induces DNA damage and alters base-excision repair and tau levels in the brain of neonatal mice,” Toxicological Sciences, vol. 123, no. 2, pp. 471–479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Lo, Y. Jou, C. Hsiao et al., “A polymorphism in the APE1 gene promoter is associated with lung cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 1, pp. 223–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Ito, K. Matsuo, N. Hamajima et al., “Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk,” Carcinogenesis, vol. 25, no. 8, pp. 1395–1401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Aǧaçhan, Ö. Küçükhüseyin, P. Aksoy et al., “Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking,” Anticancer Research, vol. 29, no. 6, pp. 2417–2420, 2009. View at Google Scholar · View at Scopus
  83. K. Osawa, A. Miyaishi, K. Uchino et al., “APEX1 Asp148glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 5, pp. 1181–1186, 2010. View at Google Scholar · View at Scopus
  84. M. Huang, C. P. Dinney, X. Lin, J. Lin, H. B. Grossman, and X. Wu, “High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. R. R. Misra, D. Ratnasinghe, J. A. Tangrea et al., “Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland,” Cancer Letters, vol. 191, no. 2, pp. 171–178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. C. Ryk, R. Kumar, R. K. Thirumaran, and S. Hou, “Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers,” Lung Cancer, vol. 54, no. 3, pp. 285–292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. P. D. Terry, D. M. Umbach, and J. A. Taylor, “APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking,” International Journal of Cancer, vol. 118, no. 12, pp. 3170–3173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Izzotti, C. Cartiglia, M. Longobardi et al., “Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke,” The FASEB Journal, vol. 18, no. 13, pp. 1559–1561, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. W. W. Au, S. A. Salama, and C. H. Sierra-Torres, “Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays,” Environmental Health Perspectives, vol. 111, no. 15, pp. 1843–1850, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Campalans, R. Amouroux, A. Bravard, B. Epe, and J. P. Radicella, “UVA irradiation induces relocalisation of the DNA repair protein hOGG1 to nuclear speckles,” Journal of Cell Science, vol. 120, no. 1, pp. 23–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. J. J. Hu, T. R. Smith, M. S. Miller, H. W. Mohrenweiser, A. Golden, and L. D. Case, “Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity,” Carcinogenesis, vol. 22, no. 6, pp. 917–922, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. J. J. Hu, T. R. Smith, M. S. Miller, K. Lohman, and L. D. Case, “Genetic regulation of ionizing radiation sensitivity and breast cancer risk,” Environmental and Molecular Mutagenesis, vol. 39, no. 2-3, pp. 208–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. M. G. Andreassi, I. Foffa, S. Manfredi, N. Botto, A. Cioppa, and E. Picano, “Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 666, no. 1-2, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. X. Gu, Y. Cun, M. Li et al., “Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-Ray irradiation in lung cancer cells,” International Journal of Medical Sciences, vol. 10, no. 7, pp. 870–882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Zhang, X. Yang, D. Wang et al., “Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells,” Cell Biochemistry and Biophysics, vol. 61, no. 3, pp. 561–572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Gdowicz-Klosok, M. Widel, and J. Rzeszowska-Wolny, “The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 755, no. 1, pp. 42–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. B. R. Berquist, D. R. McNeill, and D. M. Wilson III, “Characterization of abasic endonuclease activity of human Ape1 on alternative substrates, as well as effects of ATP and sequence context on AP site incision,” Journal of Molecular Biology, vol. 379, no. 1, pp. 17–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. P. F. Liu and B. Demple, “DNA repair in mammalian mitochondria: much more than we thought?” Environmental and Molecular Mutagenesis, vol. 51, no. 5, pp. 417–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Barnes, W. Kim, A. K. Mantha et al., “Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA,” Nucleic Acids Research, vol. 37, no. 12, pp. 3946–3958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. J. E. J. Guikema, E. K. Linehan, D. Tsuchimoto et al., “APE1- And APE2-dependent DNA breaks in immunoglobulin class switch recombination,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 3017–3026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Masani, L. Han, and K. Yu, “Apurinic/apyrimidinic endonuclease 1 is the essential nuclease during immunoglobulin class switch recombination,” Molecular and Cellular Biology, vol. 33, no. 7, pp. 1468–1473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. L. B. Chiarini, F. G. Freitas, H. Petrs-Silva, and R. Linden, “Evidence that the bifunctional redox factor/AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina,” Cell Death and Differentiation, vol. 7, no. 3, pp. 272–281, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Abbotts and S. Madhusudan, “Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer,” Cancer Treatment Reviews, vol. 36, no. 5, pp. 425–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. M. L. Fishel, Y. He, A. M. Reed et al., “Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth,” DNA Repair, vol. 7, no. 2, pp. 177–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. L. Jiang, S. Y. Zhou, G. E. Sandusky, M. R. Kelley, and M. L. Fishel, “Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression,” Cancer Investigation, vol. 28, no. 9, pp. 885–895, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. D. H. Moore, H. Michael, R. Tritt, S. H. Parsons, and M. R. Kelley, “Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers,” Clinical Cancer Research, vol. 6, no. 2, pp. 602–609, 2000. View at Google Scholar · View at Scopus
  107. G. Tell, L. Pellizzari, C. Pucillo et al., “TSH controls Ref-1 nuclear translocation in thyroid cells,” Journal of Molecular Endocrinology, vol. 24, no. 3, pp. 383–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Wang, M. Luo, and M. R. Kelley, “Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition,” Molecular Cancer Therapeutics, vol. 3, no. 6, pp. 679–686, 2004. View at Google Scholar · View at Scopus
  109. C. J. Herring, C. M. L. West, D. P. Wilks et al., “Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers,” British Journal of Cancer, vol. 78, no. 9, pp. 1128–1133, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. D.-B. Xiang, Z.-T. Chen, D. Wang et al., “Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo,” Cancer Gene Therapy, vol. 15, no. 10, pp. 625–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Chen, G. Xiong, S. Wu, and J. Mo, “Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro,” Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 2, pp. 169–176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. K. A. Robertson, H. A. Bullock, Y. Xu et al., “Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation,” Cancer Research, vol. 61, no. 5, pp. 2220–2225, 2001. View at Google Scholar · View at Scopus
  113. T. Xi, I. M. Jones, and H. W. Mohrenweiser, “Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function,” Genomics, vol. 83, no. 6, pp. 970–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Z. Hadi, M. A. Coleman, K. Fidelis, H. W. Mohrenweiser, and D. M. Wilson III, “Functional characterization of Ape1 variants identified in the human population,” Nucleic Acids Research, vol. 28, no. 20, pp. 3871–3879, 2000. View at Publisher · View at Google Scholar · View at Scopus
  115. R. J. Hung, J. Hall, P. Brennan, and P. Boffetta, “Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review,” The American Journal of Epidemiology, vol. 162, no. 10, pp. 925–942, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Canbay, B. Agachan, M. Gulluoglu et al., “Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer,” Anticancer Research, vol. 30, no. 4, pp. 1359–1364, 2010. View at Google Scholar · View at Scopus
  117. E. Canbay, B. Cakmakoglu, U. Zeybek et al., “Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population,” Current Medical Research and Opinion, vol. 27, no. 7, pp. 1295–1302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Chen, C. B. Ambrosone, J. Lee, T. A. Sellers, J. Pow-Sang, and J. Y. Park, “Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans,” Journal of Urology, vol. 175, no. 1, pp. 108–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Li, Z. Liu, L. Wang et al., “Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma,” Carcinogenesis, vol. 27, no. 9, pp. 1894–1901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Li, S. Li, Z. Wu et al., “Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a Northeast Chinese population,” Medical Oncology, vol. 30, no. 2, article no. 505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. H. F. Kang, Z. J. Dai, X. B. Ma et al., “A genetic variant in the promoter of APE1 gene (−656 T > G) is associated with breast cancer risk and progression in a Chinese population,” Gene, vol. 531, no. 1, pp. 97–100, 2013. View at Google Scholar
  122. M. Wang, H. Chu, S. Wang et al., “Genetic variant in APE1 gene promoter contributes to cervical cancer risk,” American Journal of Obstetrics and Gynecology, vol. 209, no. 4, pp. 360.e1–360.e7, 2013. View at Google Scholar
  123. M. L. Wang, C. Qin, J. A. Zhu et al., “Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer,” DNA and Cell Biology, vol. 29, no. 6, pp. 303–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Lu, S. Y. Zhang, D. Chen et al., “Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility,” The FASEB Journal, vol. 23, no. 10, pp. 3459–3469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. Z. Li, W. Guan, M. Li et al., “Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population,” Archives of Medical Research, vol. 42, no. 3, pp. 226–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. Y. Ji, P. Zhan, J. Wang, L. Qiu, and L. Yu, “APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis,” Molecular Biology Reports, vol. 38, no. 7, pp. 4537–4543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. Q. Deng, L. Sheng, D. Su et al., “Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China,” Medical Oncology, vol. 28, no. 3, pp. 667–672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. D. M. Wilson III and D. R. McNeill, “Base excision repair and the central nervous system,” Neuroscience, vol. 145, no. 4, pp. 1187–1200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. M. R. Vasko, C. Guo, and M. R. Kelley, “The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress,” DNA Repair, vol. 4, no. 3, pp. 367–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  130. Z. Tan, N. Sun, and S. S. Schreiber, “Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer’s hippocampus,” NeuroReport, vol. 9, no. 12, pp. 2749–2752, 1998. View at Publisher · View at Google Scholar · View at Scopus
  131. G. Marcon, G. Tell, L. Perrone et al., “APE1/Ref-1 in Alzheimer’s disease: An immunohistochemical study,” Neuroscience Letters, vol. 466, no. 3, pp. 124–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. G. E. Kisby, J. Milne, and C. Sweatt, “Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue,” NeuroReport, vol. 8, no. 6, pp. 1337–1340, 1997. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Gencer, S. Dasdemir, B. Cakmakoglu et al., “DNA repair genes in Parkinson’s disease,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 6, pp. 504–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. Z. L. Olkowski, “Mutant AP endonuclease in patients with amyotrophic lateral sclerosis,” NeuroReport, vol. 9, no. 2, pp. 239–242, 1998. View at Publisher · View at Google Scholar · View at Scopus
  135. V. A. Bohr, “Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells,” Free Radical Biology and Medicine, vol. 32, no. 9, pp. 804–812, 2002. View at Publisher · View at Google Scholar · View at Scopus
  136. G. W. Intano, E. J. Cho, C. A. McMahan, and C. A. Walter, “Age-related base excision repair activity in mouse brain and liver nuclear extracts,” Journals of Gerontology A, vol. 58, no. 3, pp. 205–211, 2003. View at Google Scholar · View at Scopus
  137. U. Swain and K. S. Rao, “Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging,” Mechanisms of Ageing and Development, vol. 132, no. 8-9, pp. 374–381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. P. Angkeow, S. S. Deshpande, B. Qi et al., “Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis,” Cell Death and Differentiation, vol. 9, no. 7, pp. 717–725, 2002. View at Publisher · View at Google Scholar · View at Scopus
  139. Y. Zhang, L. Zhang, L. Zhang, J. Bai, H. Y. Ge, and P. Liu, “Expression changes in DNA repair enzymes and mitochondrial DNA damage in aging rat lens,” Molecular Vision, vol. 16, pp. 1754–1763, 2010. View at Google Scholar · View at Scopus
  140. B. Szczesny and S. Mitra, “Effect of aging on intracellular distribution of abasic (AP) endonuclease 1 in the mouse liver,” Mechanisms of Ageing and Development, vol. 126, no. 10, pp. 1071–1078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Madlener, T. Strobel, S. Vose et al., “Essential role for mammalian apurinic/apyrimidinic (AP) endonuclease Ape1/Ref-1 in telomere maintenance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 44, pp. 17844–17849, 2013. View at Google Scholar
  142. A. Tekeli, S. Isbir, A. Ergen et al., “APE1 and XRCC3 polymorphisms and myocardial infarction,” In Vivo, vol. 22, no. 4, pp. 477–480, 2008. View at Google Scholar · View at Scopus
  143. A. Bardia, S. K. Tiwari, S. Gunisetty et al., “Functional polymorphisms in XRCC-1 and APE-1 contribute to increased apoptosis and risk of ulcerative colitis,” Inflammation Research, vol. 61, no. 4, pp. 359–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. A. Jiang, H. Gao, M. R. Kelley, and X. Qiao, “Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo,” Vision Research, vol. 51, no. 1, pp. 93–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. P. Carmeliet, Y. Dor, J. M. Herbert et al., “Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis,” Nature, vol. 394, no. 6692, pp. 485–490, 1998. View at Google Scholar
  146. R. F. Gariano and T. W. Gardner, “Retinal angiogenesis in development and disease,” Nature, vol. 438, no. 7070, pp. 960–966, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. A. d’Errico, N. Malats, P. Vineis, and P. Boffetta, “Review of studies of selected metabolic polymorphisms and cancer.,” IARC scientific publications, no. 148, pp. 323–393, 1999. View at Google Scholar · View at Scopus
  148. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Some drinking-water disinfectants and contaminants, including arsenic,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 84, pp. 1–477, 2004. View at Google Scholar
  149. A. D. Kligerman and A. H. Tennant, “Insights into the carcinogenic mode of action of arsenic,” Toxicology and Applied Pharmacology, vol. 222, no. 3, pp. 281–288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. A. Szymańska-Chabowska, J. Antonowicz-Juchniewicz, and R. Andrzejak, “The concentration of selected cancer markers (TPA, TPS, CYFRA 21-1, CEA) in workers occupationally exposed to arsenic (As) and some heavy metals (Pb, Cd) during a two-year observation study,” International Journal of Occupational Medicine and Environmental Health, vol. 20, no. 3, pp. 229–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. A. Díaz-Villaseñor, A. L. Burns, M. Hiriart, M. E. Cebrián, and P. Ostrosky-Wegman, “Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus,” Toxicology and Applied Pharmacology, vol. 225, no. 2, pp. 123–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. E. M. Schmuck, P. G. Board, A. K. Whitbread et al., “Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer’s and Parkinson’s diseases,” Pharmacogenetics and Genomics, vol. 15, no. 7, pp. 493–501, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. A. Vahidnia, G. B. van der Voet, and F. A. de Wolff, “Arsenic neurotoxicity—a review,” Human and Experimental Toxicology, vol. 26, no. 10, pp. 823–832, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. C. Huang, Q. D. Ke, M. Costa, and X. Shi, “Molecular mechanisms of arsenic carcinogenesis,” Molecular and Cellular Biochemistry, vol. 255, no. 1-2, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. E. T. Snow, P. Sykora, T. R. Durham, and C. B. Klein, “Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?” Toxicology and Applied Pharmacology, vol. 207, supplememet 1, no. 2, pp. 557–564, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. J. Lunec, K. A. Holloway, M. S. Cooke, S. Faux, H. R. Griffiths, and M. D. Evans, “Urinary 8-oxo-2′-deoxyguanosine: redox regulation of DNA repair in vivo?” Free Radical Biology and Medicine, vol. 33, no. 7, pp. 875–885, 2002. View at Publisher · View at Google Scholar · View at Scopus
  157. P. Vodicka, R. Stetina, V. Polakova et al., “Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects,” Carcinogenesis, vol. 28, no. 3, pp. 657–664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. “Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions, Lyon, 9–16 February 1993,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 58, pp. 1–415, 1993.
  159. M. P. Waalkes, “Cadmium carcinogenesis,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 533, no. 1-2, pp. 107–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  160. M. Waisberg, P. Joseph, B. Hale, and D. Beyersmann, “Molecular and cellular mechanisms of cadmium carcinogenesis,” Toxicology, vol. 192, no. 2-3, pp. 95–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. G. Bertin and D. Averbeck, “Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review),” Biochimie, vol. 88, no. 11, pp. 1549–1559, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. P. Joseph, “Mechanisms of cadmium carcinogenesis,” Toxicology and Applied Pharmacology, vol. 238, no. 3, pp. 272–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. M. L. Hegde, T. K. Hazra, and S. Mitra, “Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells,” Cell Research, vol. 18, no. 1, pp. 27–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. C. Giaginis, E. Gatzidou, and S. Theocharis, “DNA repair systems as targets of cadmium toxicity,” Toxicology and Applied Pharmacology, vol. 213, no. 3, pp. 282–290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  165. “Lead and lead compounds: lead and inorganic lead compounds,” IARC Monographs Evaluation Carcinogenic Risks to Humans, vol. 23, supplement 7, pp. 1–729, 1987.
  166. “Inorganic and organic lead compounds,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 87, pp. 1–471, 2006.
  167. L. Järup, “Hazards of heavy metal contamination,” British Medical Bulletin, vol. 68, pp. 167–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  168. J. Patocka and K. Cerný, “Inorganic lead toxicology,” Acta Medica, vol. 46, no. 2, pp. 65–72, 2003. View at Google Scholar · View at Scopus
  169. J. Méndez-Gómez, G. García-Vargas, L. López-Carrillo et al., “Genotoxic effects of environmental exposure to arsenic and lead on children in Region Lagunera, Mexico,” Annals of the New York Academy of Sciences, vol. 1140, pp. 358–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. J. Garcia-Leston, J. Mendez, E. Pasaro, and B. Laffon, “Genotoxic effects of lead: an updated review,” Environment International, vol. 36, no. 6, pp. 623–636, 2010. View at Google Scholar
  171. D. R. McNeill, H. Wong, A. Narayana, and D. M. Wilson III, “Lead promotes abasic site accumulation and co-mutagenesis in mammalian cells by inhibiting the major abasic endonuclease Ape1,” Molecular Carcinogenesis, vol. 46, no. 2, pp. 91–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Grösch, G. Fritz, and B. Kaina, “Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation,” Cancer Research, vol. 58, no. 19, pp. 4410–4416, 1998. View at Google Scholar · View at Scopus
  173. C. V. Ramana, I. Boldogh, T. Izumi, and S. Mitra, “Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5061–5066, 1998. View at Publisher · View at Google Scholar · View at Scopus
  174. P. Boyle, “Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996,” Lung Cancer, vol. 17, no. 1, pp. 1–60, 1997. View at Publisher · View at Google Scholar · View at Scopus
  175. S. S. Hecht, “Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention,” The Lancet Oncology, vol. 3, no. 8, pp. 461–469, 2002. View at Publisher · View at Google Scholar · View at Scopus
  176. Q. Wei and M. R. Spitz, “The role of DNA repair capacity in susceptibility to lung cancer: a review,” Cancer and Metastasis Reviews, vol. 16, no. 3-4, pp. 295–307, 1997. View at Publisher · View at Google Scholar · View at Scopus
  177. M. R. Spitz, X. Wu, Y. Wang et al., “Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients,” Cancer Research, vol. 61, no. 4, pp. 1354–1357, 2001. View at Google Scholar · View at Scopus
  178. Q. Wei, L. Cheng, W. K. Hong, and M. R. Spitz, “Reduced DNA repair capacity in lung cancer patients,” Cancer Research, vol. 56, no. 18, pp. 4103–4107, 1996. View at Google Scholar · View at Scopus
  179. H. Shen, M. R. Spitz, Y. Qiao et al., “Smoking, DNA repair capacity and risk of nonsmall cell lung cancer,” International Journal of Cancer, vol. 107, no. 1, pp. 84–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. C. N. Kundu, R. Balusu, A. S. Jaiswal, C. G. Gairola, and S. Narayan, “Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells,” Oncogene, vol. 26, no. 10, pp. 1428–1438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. P. Mohapatra, S. R. Satapathy, D. Das et al., “Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway,” Toxicology and Applied Pharmacology, vol. 275, no. 3, pp. 221–231, 2014. View at Google Scholar
  182. A. S. Jaiswal, H. Panda, C. A. Pampo et al., “Adenomatous polyposis coli- mediated accumulation of abasic dna lesions lead to cigarette smoke condensate- induced neoplastic transformation of normal breast epithelial cells,” Neoplasia, vol. 15, no. 4, pp. 454–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  183. E. Ron, “Ionizing radiation and cancer risk: evidence from epidemiology,” Radiation Research, vol. 150, no. 5, pp. S30–S41, 1998. View at Publisher · View at Google Scholar · View at Scopus
  184. D. J. Brenner, R. Doll, D. T. Goodhead et al., “Cancer risks attributable to low doses of ionizing radiation: assessing what we really know,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 13761–13766, 2003. View at Publisher · View at Google Scholar · View at Scopus
  185. E. J. Hall and D. J. Brenner, “Cancer risks from diagnostic radiology,” British Journal of Radiology, vol. 81, no. 965, pp. 362–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. D. J. Brenner, “Should we be concerned about the rapid increase in CT usage?” Reviews on Environmental Health, vol. 25, no. 1, pp. 63–67, 2010. View at Google Scholar · View at Scopus
  187. M. de Santis, E. Cesari, E. Nobili, G. Straface, A. F. Cavaliere, and A. Caruso, “Radiation effects on development,” Birth Defects Research C: Embryo Today: Reviews, vol. 81, no. 3, pp. 177–182, 2007. View at Publisher · View at Google Scholar · View at Scopus